

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42619591 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.13902959 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.13902959 |
| 4 | leukocyte aggregation (GO:0070486) | 4.67018644 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64635186 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60120523 |
| 7 | tolerance induction (GO:0002507) | 4.51056944 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.28265743 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.13356872 |
| 10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.11728429 |
| 11 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.04108877 |
| 12 | response to interleukin-15 (GO:0070672) | 4.02990720 |
| 13 | interferon-gamma production (GO:0032609) | 4.00216943 |
| 14 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.99995148 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98833550 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.98427677 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.96643701 |
| 18 | negative regulation of cell killing (GO:0031342) | 3.96643701 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.96117851 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.96117851 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.96117851 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.96117851 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.96117851 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.96117851 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 3.76881525 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.76031391 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.75320944 |
| 28 | negative T cell selection (GO:0043383) | 3.74191853 |
| 29 | response to peptidoglycan (GO:0032494) | 3.70283665 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.67487674 |
| 31 | regulation of tolerance induction (GO:0002643) | 3.60450813 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 3.59421907 |
| 33 | positive regulation of tolerance induction (GO:0002645) | 3.58243650 |
| 34 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56331988 |
| 35 | response to protozoan (GO:0001562) | 3.55899347 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.53250033 |
| 37 | respiratory burst (GO:0045730) | 3.53096234 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.51581962 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.50228967 |
| 40 | defense response to protozoan (GO:0042832) | 3.46308501 |
| 41 | T cell migration (GO:0072678) | 3.45541233 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.42621232 |
| 43 | positive thymic T cell selection (GO:0045059) | 3.42357256 |
| 44 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.36222361 |
| 45 | positive regulation of B cell mediated immunity (GO:0002714) | 3.36222361 |
| 46 | detection of other organism (GO:0098543) | 3.34366932 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34197537 |
| 48 | positive regulation of isotype switching (GO:0045830) | 3.30544109 |
| 49 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.30487821 |
| 50 | myeloid dendritic cell activation (GO:0001773) | 3.30463196 |
| 51 | neutrophil mediated immunity (GO:0002446) | 3.25832135 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.25753377 |
| 53 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.25501972 |
| 54 | granulocyte activation (GO:0036230) | 3.23948745 |
| 55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.23611129 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22633008 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.21876480 |
| 58 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.21876480 |
| 59 | neutrophil activation (GO:0042119) | 3.21708173 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.21431522 |
| 61 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.20857138 |
| 62 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.19647493 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.17573465 |
| 64 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17566375 |
| 65 | mast cell activation (GO:0045576) | 3.16078465 |
| 66 | positive regulation of interleukin-2 production (GO:0032743) | 3.15379369 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.15192296 |
| 68 | detection of bacterium (GO:0016045) | 3.15094604 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.14204142 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.13563763 |
| 71 | myeloid dendritic cell differentiation (GO:0043011) | 3.12430167 |
| 72 | positive regulation of humoral immune response (GO:0002922) | 3.12241850 |
| 73 | regulation of regulatory T cell differentiation (GO:0045589) | 3.11816748 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 3.11263924 |
| 75 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10855973 |
| 76 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.10376430 |
| 77 | regulation of growth of symbiont in host (GO:0044126) | 3.10376430 |
| 78 | negative regulation of growth of symbiont in host (GO:0044130) | 3.10376430 |
| 79 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.10376430 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.08276597 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 3.08245924 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07775506 |
| 83 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.06459649 |
| 84 | leukocyte cell-cell adhesion (GO:0007159) | 3.05211884 |
| 85 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.03801210 |
| 86 | regulation of immunoglobulin secretion (GO:0051023) | 3.00559042 |
| 87 | positive regulation of interleukin-17 production (GO:0032740) | 2.98369875 |
| 88 | regulation of chemokine biosynthetic process (GO:0045073) | 2.97336355 |
| 89 | T cell proliferation (GO:0042098) | 2.94292261 |
| 90 | cellular extravasation (GO:0045123) | 2.93600251 |
| 91 | macrophage activation involved in immune response (GO:0002281) | 2.92914478 |
| 92 | activated T cell proliferation (GO:0050798) | 2.92346583 |
| 93 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.91925714 |
| 94 | regulation of chronic inflammatory response (GO:0002676) | 2.91681105 |
| 95 | lymphocyte chemotaxis (GO:0048247) | 2.91220831 |
| 96 | thymic T cell selection (GO:0045061) | 2.90645139 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 2.90034676 |
| 98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89890425 |
| 99 | regulation of B cell mediated immunity (GO:0002712) | 2.89341528 |
| 100 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.89294518 |
| 101 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.86107201 |
| 102 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.85661911 |
| 103 | regulation of interleukin-17 production (GO:0032660) | 2.85186471 |
| 104 | regulation of response to interferon-gamma (GO:0060330) | 2.84690871 |
| 105 | response to type I interferon (GO:0034340) | 2.84688834 |
| 106 | cellular response to type I interferon (GO:0071357) | 2.84258011 |
| 107 | type I interferon signaling pathway (GO:0060337) | 2.84258011 |
| 108 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.84184857 |
| 109 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83968550 |
| 110 | positive regulation of interferon-gamma production (GO:0032729) | 2.83416166 |
| 111 | lymphocyte migration (GO:0072676) | 2.83217932 |
| 112 | positive regulation of DNA recombination (GO:0045911) | 2.82804148 |
| 113 | dendritic cell chemotaxis (GO:0002407) | 2.82509657 |
| 114 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.81426098 |
| 115 | B cell mediated immunity (GO:0019724) | 2.81249947 |
| 116 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.80190344 |
| 117 | T cell selection (GO:0045058) | 2.79767818 |
| 118 | negative regulation of interleukin-6 production (GO:0032715) | 2.79669099 |
| 119 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.79307078 |
| 120 | positive T cell selection (GO:0043368) | 2.79119122 |
| 121 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.78713679 |
| 122 | negative regulation of innate immune response (GO:0045824) | 2.78102889 |
| 123 | T cell costimulation (GO:0031295) | 2.77626864 |
| 124 | regulation of leukocyte degranulation (GO:0043300) | 2.76689506 |
| 125 | detection of external biotic stimulus (GO:0098581) | 2.76102675 |
| 126 | microglial cell activation (GO:0001774) | 2.75024607 |
| 127 | regulation of alpha-beta T cell activation (GO:0046634) | 2.74780689 |
| 128 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.74460555 |
| 129 | leukocyte degranulation (GO:0043299) | 2.74020571 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73567915 |
| 131 | regulation of mast cell activation (GO:0033003) | 2.73415009 |
| 132 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72546571 |
| 133 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.70825858 |
| 134 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.70531787 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.67953240 |
| 136 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.66434456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.18713927 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.67289158 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.02095760 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60547639 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30013329 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.55459696 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.51765821 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40488998 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40126797 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.35734403 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.32344422 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.24700028 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19596661 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18260711 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.16710373 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.91131887 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64760204 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.64680773 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.62118169 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.54968246 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49416762 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.46449307 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.29536068 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28071745 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24766305 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21341005 |
| 27 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18740176 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18206292 |
| 29 | * MYB_26560356_Chip-Seq_TH1_Human | 2.14476488 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 2.10939757 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08229623 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05550290 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04660603 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02118101 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01446575 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98086771 |
| 37 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.84997994 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78461780 |
| 39 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.68248211 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67889459 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64384696 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63896860 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58916593 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55600784 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53671726 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49898860 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45545884 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43770612 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43223877 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40201008 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38905142 |
| 52 | * MAF_26560356_Chip-Seq_TH2_Human | 1.36857790 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36757363 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28987856 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27974373 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27376631 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25706871 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25070458 |
| 59 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21696506 |
| 60 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21031616 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19378988 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18747077 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18519312 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18078161 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16469648 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16434143 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15286788 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14837035 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13173748 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09809728 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08424977 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07691648 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03072059 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02600436 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01916695 |
| 76 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01910934 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01231413 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00866141 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00105191 |
| 80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00030486 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99288684 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98538088 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98245739 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97213251 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94112419 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94022216 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93534199 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93379021 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90352420 |
| 90 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89597273 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88827098 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88596321 |
| 93 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.85974150 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85782146 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85481562 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84526511 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83004122 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81651854 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78518559 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77988713 |
| 101 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76175822 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75779685 |
| 103 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.74891684 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74765828 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74356310 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.72665363 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72600943 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72130760 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.70859058 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70158955 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68125730 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.67756629 |
| 113 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.66234886 |
| 114 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65506047 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.63473314 |
| 116 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.63455996 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.62222965 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.62222965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.88872101 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.81242787 |
| 3 | MP0003724_increased_susceptibility_to | 3.58424687 |
| 4 | MP0009785_altered_susceptibility_to | 3.54812734 |
| 5 | MP0005671_abnormal_response_to | 3.37507779 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.13260702 |
| 7 | MP0003303_peritoneal_inflammation | 3.08616425 |
| 8 | MP0000685_abnormal_immune_system | 2.89469178 |
| 9 | * MP0002419_abnormal_innate_immunity | 2.84903776 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.84884730 |
| 11 | MP0001800_abnormal_humoral_immune | 2.78296182 |
| 12 | MP0005387_immune_system_phenotype | 2.76775911 |
| 13 | MP0001790_abnormal_immune_system | 2.76775911 |
| 14 | * MP0005025_abnormal_response_to | 2.76211660 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.65458980 |
| 16 | MP0002723_abnormal_immune_serum | 2.60717423 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.55844512 |
| 18 | MP0002405_respiratory_system_inflammati | 2.51417726 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.47752604 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.44214318 |
| 21 | * MP0001819_abnormal_immune_cell | 2.42253315 |
| 22 | MP0006082_CNS_inflammation | 2.31022145 |
| 23 | MP0001853_heart_inflammation | 2.29072392 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.17876924 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.17729382 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.04907930 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.03860325 |
| 28 | MP0002398_abnormal_bone_marrow | 2.01173466 |
| 29 | MP0004510_myositis | 1.97889481 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.97612675 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.95121609 |
| 32 | * MP0000716_abnormal_immune_system | 1.92103015 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.88709695 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.87682538 |
| 35 | MP0002006_tumorigenesis | 1.84426303 |
| 36 | MP0004947_skin_inflammation | 1.77826481 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.75766348 |
| 38 | MP0000343_altered_response_to | 1.74390310 |
| 39 | MP0002722_abnormal_immune_system | 1.68411288 |
| 40 | MP0003866_abnormal_defecation | 1.67545945 |
| 41 | MP0002933_joint_inflammation | 1.63265658 |
| 42 | MP0000858_altered_metastatic_potential | 1.62890242 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.59120531 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.59120531 |
| 45 | MP0008469_abnormal_protein_level | 1.58599086 |
| 46 | * MP0002429_abnormal_blood_cell | 1.58153848 |
| 47 | MP0009764_decreased_sensitivity_to | 1.57770150 |
| 48 | MP0001873_stomach_inflammation | 1.55321602 |
| 49 | * MP0003448_altered_tumor_morphology | 1.55253575 |
| 50 | MP0009278_abnormal_bone_marrow | 1.47540767 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.40698555 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.38832036 |
| 53 | MP0001851_eye_inflammation | 1.35252603 |
| 54 | * MP0003075_altered_response_to | 1.31937941 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.28564620 |
| 56 | MP0008004_abnormal_stomach_pH | 1.28406464 |
| 57 | MP0005451_abnormal_body_composition | 1.28354914 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.25601102 |
| 59 | MP0005166_decreased_susceptibility_to | 1.19783228 |
| 60 | MP0005310_abnormal_salivary_gland | 1.11081222 |
| 61 | MP0000490_abnormal_crypts_of | 1.08622305 |
| 62 | MP0009763_increased_sensitivity_to | 1.07851933 |
| 63 | MP0003828_pulmonary_edema | 1.07790616 |
| 64 | * MP0005164_abnormal_response_to | 1.07674570 |
| 65 | MP0001881_abnormal_mammary_gland | 1.05692896 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.05435156 |
| 67 | MP0006054_spinal_hemorrhage | 1.04387898 |
| 68 | MP0005390_skeleton_phenotype | 1.01171632 |
| 69 | MP0004883_abnormal_blood_vessel | 1.00317338 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.99699255 |
| 71 | MP0005023_abnormal_wound_healing | 0.99680385 |
| 72 | MP0003172_abnormal_lysosome_physiology | 0.97815170 |
| 73 | MP0008260_abnormal_autophagy | 0.95534622 |
| 74 | MP0002132_abnormal_respiratory_system | 0.94874034 |
| 75 | * MP0003690_abnormal_glial_cell | 0.92276189 |
| 76 | MP0000249_abnormal_blood_vessel | 0.91817162 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.91077018 |
| 78 | MP0002009_preneoplasia | 0.87345145 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.86148562 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.85805416 |
| 81 | MP0001542_abnormal_bone_strength | 0.84182634 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.81149192 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.80277827 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.79486709 |
| 85 | * MP0000604_amyloidosis | 0.77628012 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.77559658 |
| 87 | MP0008873_increased_physiological_sensi | 0.76431597 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.76072826 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.75984609 |
| 90 | MP0000609_abnormal_liver_physiology | 0.75424720 |
| 91 | MP0009840_abnormal_foam_cell | 0.75361341 |
| 92 | * MP0002019_abnormal_tumor_incidence | 0.74846475 |
| 93 | * MP0003795_abnormal_bone_structure | 0.73002468 |
| 94 | MP0003186_abnormal_redox_activity | 0.71610178 |
| 95 | MP0010307_abnormal_tumor_latency | 0.69213951 |
| 96 | MP0003279_aneurysm | 0.69114370 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.68645729 |
| 98 | MP0002254_reproductive_system_inflammat | 0.67549327 |
| 99 | MP0003045_fibrosis | 0.67042747 |
| 100 | MP0001663_abnormal_digestive_system | 0.66860840 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.65007539 |
| 102 | MP0008874_decreased_physiological_sensi | 0.63359748 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.61258492 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.60823692 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.60327595 |
| 106 | MP0004130_abnormal_muscle_cell | 0.58466440 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.55655864 |
| 108 | MP0001243_abnormal_dermal_layer | 0.55134010 |
| 109 | MP0000920_abnormal_myelination | 0.55090741 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.53184688 |
| 111 | MP0003091_abnormal_cell_migration | 0.52586054 |
| 112 | MP0000598_abnormal_liver_morphology | 0.51714904 |
| 113 | * MP0005165_increased_susceptibility_to | 0.50024017 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.50021013 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 0.48530120 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.48224136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.27739421 |
| 2 | Myositis (HP:0100614) | 6.20758465 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.74170766 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.54591614 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.42942132 |
| 6 | Optic neuritis (HP:0100653) | 5.42942132 |
| 7 | Orchitis (HP:0100796) | 5.40596077 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 5.01116666 |
| 9 | Stomatitis (HP:0010280) | 4.98305123 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.43399530 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.32725220 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.09748082 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.07670257 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 4.00208972 |
| 15 | IgM deficiency (HP:0002850) | 3.77309471 |
| 16 | Pulmonary infiltrates (HP:0002113) | 3.77286045 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.71710405 |
| 18 | Obstructive lung disease (HP:0006536) | 3.71710405 |
| 19 | Keratoconjunctivitis (HP:0001096) | 3.66883261 |
| 20 | Vasculitis (HP:0002633) | 3.62304741 |
| 21 | T lymphocytopenia (HP:0005403) | 3.51403231 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.49261820 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.49261820 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.49261820 |
| 25 | Recurrent viral infections (HP:0004429) | 3.45812022 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.45562351 |
| 27 | Recurrent skin infections (HP:0001581) | 3.37603311 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.36392991 |
| 29 | Chronic otitis media (HP:0000389) | 3.35567879 |
| 30 | Gingivitis (HP:0000230) | 3.33581867 |
| 31 | Hemoptysis (HP:0002105) | 3.27600255 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.25398374 |
| 33 | Arterial thrombosis (HP:0004420) | 3.24218660 |
| 34 | Abnormality of T cells (HP:0002843) | 3.23303058 |
| 35 | Pustule (HP:0200039) | 3.22502223 |
| 36 | Meningitis (HP:0001287) | 3.20679931 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.11604947 |
| 38 | Periodontitis (HP:0000704) | 3.08264267 |
| 39 | Spontaneous hematomas (HP:0007420) | 3.07567357 |
| 40 | Thrombocytosis (HP:0001894) | 3.05369487 |
| 41 | Recurrent bronchitis (HP:0002837) | 3.01756126 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.95754582 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.95069880 |
| 44 | Petechiae (HP:0000967) | 2.86236347 |
| 45 | Increased IgE level (HP:0003212) | 2.85895030 |
| 46 | Leukocytosis (HP:0001974) | 2.85195579 |
| 47 | Joint swelling (HP:0001386) | 2.79596553 |
| 48 | Anorexia (HP:0002039) | 2.79196591 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 2.79178500 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78573610 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78573610 |
| 52 | Increased serum ferritin (HP:0003281) | 2.75913083 |
| 53 | Gangrene (HP:0100758) | 2.71540094 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.70785471 |
| 55 | IgA deficiency (HP:0002720) | 2.67304153 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.66188793 |
| 57 | Nasal polyposis (HP:0100582) | 2.63471490 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61768587 |
| 59 | Amyloidosis (HP:0011034) | 2.61765238 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.61543911 |
| 61 | Episodic fever (HP:0001954) | 2.61507324 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.61206635 |
| 63 | Hematochezia (HP:0002573) | 2.58801685 |
| 64 | Increased IgM level (HP:0003496) | 2.57677673 |
| 65 | Pulmonary embolism (HP:0002204) | 2.57096711 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.56826348 |
| 67 | Eosinophilia (HP:0001880) | 2.55735484 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.55217067 |
| 69 | Loss of speech (HP:0002371) | 2.49190415 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.48858709 |
| 71 | IgG deficiency (HP:0004315) | 2.48364981 |
| 72 | Encephalitis (HP:0002383) | 2.48260973 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.46938271 |
| 74 | Gingival bleeding (HP:0000225) | 2.46928268 |
| 75 | Increased density of long bones (HP:0006392) | 2.44796997 |
| 76 | Prostate neoplasm (HP:0100787) | 2.44396701 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 2.43701749 |
| 78 | Chronic diarrhea (HP:0002028) | 2.43674419 |
| 79 | Cheilitis (HP:0100825) | 2.42996588 |
| 80 | Colitis (HP:0002583) | 2.39768037 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.36349750 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.35303514 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.35135397 |
| 84 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35103275 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.35093277 |
| 86 | Urticaria (HP:0001025) | 2.34454908 |
| 87 | Granulocytopenia (HP:0001913) | 2.33994894 |
| 88 | Epistaxis (HP:0000421) | 2.32091883 |
| 89 | Osteomyelitis (HP:0002754) | 2.30560019 |
| 90 | Cellulitis (HP:0100658) | 2.30456024 |
| 91 | Persistence of primary teeth (HP:0006335) | 2.27430263 |
| 92 | Lymphopenia (HP:0001888) | 2.26836913 |
| 93 | Abnormality of the pericardium (HP:0001697) | 2.25694075 |
| 94 | Skin ulcer (HP:0200042) | 2.23304438 |
| 95 | Inflammation of the large intestine (HP:0002037) | 2.22704449 |
| 96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.21747167 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.21052971 |
| 98 | Glomerulopathy (HP:0100820) | 2.20567035 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 2.16955135 |
| 100 | Hypertensive crisis (HP:0100735) | 2.15745640 |
| 101 | Gastrointestinal stroma tumor (HP:0100723) | 2.15675015 |
| 102 | Chest pain (HP:0100749) | 2.15418882 |
| 103 | Vertigo (HP:0002321) | 2.14191655 |
| 104 | Polyneuropathy (HP:0001271) | 2.13933110 |
| 105 | Joint hemorrhage (HP:0005261) | 2.13525379 |
| 106 | Arthralgia (HP:0002829) | 2.11305243 |
| 107 | Agammaglobulinemia (HP:0004432) | 2.08793278 |
| 108 | Acne (HP:0001061) | 2.08748836 |
| 109 | Gastrointestinal inflammation (HP:0004386) | 2.07668146 |
| 110 | Keratitis (HP:0000491) | 2.07331616 |
| 111 | Myocardial infarction (HP:0001658) | 2.07287771 |
| 112 | Amaurosis fugax (HP:0100576) | 2.05518443 |
| 113 | Nonimmune hydrops fetalis (HP:0001790) | 2.03916073 |
| 114 | Lymphoma (HP:0002665) | 2.03645011 |
| 115 | B lymphocytopenia (HP:0010976) | 2.03608407 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03176303 |
| 117 | Abnormal platelet volume (HP:0011876) | 2.00816716 |
| 118 | Prolonged bleeding time (HP:0003010) | 2.00643049 |
| 119 | Purpura (HP:0000979) | 1.98694202 |
| 120 | Thrombophlebitis (HP:0004418) | 1.97332681 |
| 121 | Glomerulonephritis (HP:0000099) | 1.96177594 |
| 122 | Peritonitis (HP:0002586) | 1.96159130 |
| 123 | Aplastic anemia (HP:0001915) | 1.94159291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.81861286 |
| 2 | MAP4K1 | 4.50659235 |
| 3 | MAP3K14 | 3.14661144 |
| 4 | TESK2 | 3.14485165 |
| 5 | JAK3 | 3.09307622 |
| 6 | ZAP70 | 2.69884284 |
| 7 | TBK1 | 2.62077075 |
| 8 | TYK2 | 2.61991166 |
| 9 | TEC | 2.52633981 |
| 10 | PRPF4B | 2.51793977 |
| 11 | IRAK4 | 2.48297332 |
| 12 | ITK | 2.46789319 |
| 13 | KIT | 2.36628982 |
| 14 | BLK | 2.31002162 |
| 15 | IKBKE | 2.24252682 |
| 16 | IRAK3 | 2.23225597 |
| 17 | RIPK4 | 2.19942290 |
| 18 | JAK1 | 2.07144572 |
| 19 | GRK7 | 1.98835924 |
| 20 | BTK | 1.96499111 |
| 21 | STK10 | 1.84346327 |
| 22 | EPHB1 | 1.83832513 |
| 23 | IKBKB | 1.76685224 |
| 24 | TAOK3 | 1.68879572 |
| 25 | KDR | 1.66049940 |
| 26 | CSK | 1.62625139 |
| 27 | ERN1 | 1.62500769 |
| 28 | SYK | 1.55599619 |
| 29 | MAP2K3 | 1.53697912 |
| 30 | FGFR4 | 1.51785437 |
| 31 | LCK | 1.51754425 |
| 32 | FES | 1.44559616 |
| 33 | HCK | 1.44468098 |
| 34 | PIM2 | 1.44342349 |
| 35 | BMPR2 | 1.43155013 |
| 36 | CLK1 | 1.37046434 |
| 37 | NME2 | 1.36965291 |
| 38 | RPS6KA4 | 1.36912677 |
| 39 | PIM1 | 1.23432316 |
| 40 | MST4 | 1.22674356 |
| 41 | JAK2 | 1.22557950 |
| 42 | CHUK | 1.17996690 |
| 43 | TGFBR2 | 1.16909248 |
| 44 | FGFR3 | 1.15907558 |
| 45 | LYN | 1.14065915 |
| 46 | GRK6 | 1.07971797 |
| 47 | MUSK | 1.06228613 |
| 48 | FLT3 | 1.02515984 |
| 49 | EPHA3 | 1.00465183 |
| 50 | TRPM7 | 0.96608396 |
| 51 | LRRK2 | 0.96063208 |
| 52 | MOS | 0.95061101 |
| 53 | NEK9 | 0.93739563 |
| 54 | EEF2K | 0.91927969 |
| 55 | NLK | 0.90046602 |
| 56 | CSF1R | 0.88982064 |
| 57 | PRKD2 | 0.86607327 |
| 58 | MAP3K13 | 0.82240480 |
| 59 | CDC42BPA | 0.81622275 |
| 60 | TNK2 | 0.78112555 |
| 61 | CAMKK2 | 0.78055724 |
| 62 | IRAK2 | 0.75464744 |
| 63 | MAP3K3 | 0.72694368 |
| 64 | IRAK1 | 0.69450213 |
| 65 | RAF1 | 0.69053968 |
| 66 | MAP3K11 | 0.68143405 |
| 67 | MAPK7 | 0.68102023 |
| 68 | MARK3 | 0.67400703 |
| 69 | PRKCQ | 0.67291544 |
| 70 | SCYL2 | 0.64416966 |
| 71 | MAP2K2 | 0.64312472 |
| 72 | PIK3CG | 0.62062612 |
| 73 | PTK6 | 0.59571648 |
| 74 | CDK6 | 0.59543320 |
| 75 | PKN2 | 0.56895060 |
| 76 | RPS6KA6 | 0.56458596 |
| 77 | MAPK4 | 0.54732946 |
| 78 | SIK3 | 0.54334324 |
| 79 | TAOK1 | 0.52750030 |
| 80 | PDGFRB | 0.52635269 |
| 81 | TRIB3 | 0.50018862 |
| 82 | ABL1 | 0.49597678 |
| 83 | MAP2K6 | 0.48122122 |
| 84 | NUAK1 | 0.48045711 |
| 85 | MAP3K6 | 0.47704856 |
| 86 | TGFBR1 | 0.47363262 |
| 87 | CAMKK1 | 0.47212116 |
| 88 | MATK | 0.46379119 |
| 89 | DDR2 | 0.45735625 |
| 90 | CDK4 | 0.45605928 |
| 91 | TAOK2 | 0.44123058 |
| 92 | RIPK1 | 0.44078183 |
| 93 | PRKCH | 0.43729455 |
| 94 | RPS6KC1 | 0.43436273 |
| 95 | RPS6KL1 | 0.43436273 |
| 96 | ALK | 0.43332818 |
| 97 | PRKCD | 0.42033579 |
| 98 | MAPK11 | 0.41774750 |
| 99 | SIK2 | 0.41482525 |
| 100 | MAPKAPK2 | 0.41207084 |
| 101 | FGR | 0.41025838 |
| 102 | EGFR | 0.40629581 |
| 103 | MAP3K12 | 0.40570226 |
| 104 | MAP3K5 | 0.39005538 |
| 105 | MAPK12 | 0.38583306 |
| 106 | HIPK2 | 0.36341015 |
| 107 | DYRK1B | 0.35710900 |
| 108 | ABL2 | 0.35057278 |
| 109 | FYN | 0.34843642 |
| 110 | PDPK1 | 0.33197478 |
| 111 | IGF1R | 0.32019673 |
| 112 | MAP3K1 | 0.31003020 |
| 113 | BCKDK | 0.30205284 |
| 114 | ADRBK2 | 0.28474258 |
| 115 | CDK9 | 0.27888259 |
| 116 | MAP3K7 | 0.26224571 |
| 117 | TTN | 0.26080911 |
| 118 | TSSK6 | 0.25372782 |
| 119 | PDK1 | 0.22656338 |
| 120 | TESK1 | 0.22047064 |
| 121 | MAPK3 | 0.21953211 |
| 122 | YES1 | 0.20296444 |
| 123 | STK4 | 0.19949838 |
| 124 | INSR | 0.19382133 |
| 125 | CAMK4 | 0.19264171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.53904204 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.30553343 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.90295056 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.69591843 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.66346798 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53013147 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.51742730 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51211066 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.50511967 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.42054491 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.34444998 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.22852668 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.21867696 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08901412 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.07427729 |
| 16 | Malaria_Homo sapiens_hsa05144 | 2.07017801 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.01065683 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00371625 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 2.00299901 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.93695424 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88331184 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.86586793 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82508319 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.80563497 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.75128692 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.73256140 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70551395 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70139656 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68831211 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57289473 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51131918 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49209464 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.48598373 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.39691557 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33222782 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.28342329 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.28059908 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.27099011 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25393585 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22462433 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21375805 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21290876 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19101660 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14953322 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.09162057 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08438747 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07671840 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01839090 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90355939 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.89971224 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88947185 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87681195 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87237807 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81028374 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.79895407 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77912767 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76888987 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76575685 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71693265 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.71389319 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69754875 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64420594 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61628652 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60524852 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59085594 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.58831405 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57699387 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56577034 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54430615 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52927696 |
| 71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46894755 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46600631 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45903512 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42937550 |
| 75 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41715039 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40774392 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37864441 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36894389 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 0.34689102 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.34535618 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34213142 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.33849927 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32362789 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30412510 |
| 85 | DNA replication_Homo sapiens_hsa03030 | 0.30016709 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.28276631 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28127673 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28070511 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28064193 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27757688 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27645612 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26269620 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25396284 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25119693 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23890882 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23615336 |
| 97 | Ribosome_Homo sapiens_hsa03010 | 0.23098498 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22638342 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21469838 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19021720 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18853060 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.18802611 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17896792 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.17864139 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16824560 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16687228 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16539451 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.15974419 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15657994 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14506547 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.14350710 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.14335247 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13224826 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11963706 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11959237 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.09985144 |

